Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution

Northcott, 2019, Medulloblastoma, Nat. Rev. Dis. Primers, 5, 11, 10.1038/s41572-019-0063-6 Wang, 2018, Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies, Annu. Rev. Neurosci., 41, 207, 10.1146/annurev-neuro-070815-013838 Moxon-Emre, 2016, Intellectual Outcome in Molecular Subgroups of Medulloblastoma, J. Clin. Oncol., 34, 4161, 10.1200/JCO.2016.66.9077 Packer, 2008, Management of and prognosis with medulloblastoma: therapy at a crossroads, Arch. Neurol., 65, 1419, 10.1001/archneur.65.11.1419 Frič, 2020, Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood, Sci. Rep., 10, 9371, 10.1038/s41598-020-66328-8 Edelstein, 2011, Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes, Neuro. Oncol., 13, 536, 10.1093/neuonc/nor015 Hovestadt, 2019, Resolving medulloblastoma cellular architecture by single-cell genomics, Nature, 572, 74, 10.1038/s41586-019-1434-6 Riemondy, 2022, Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma, Neuro Oncol, 24, 273, 10.1093/neuonc/noab135 Griesinger, 2013, Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types, J.I., 191, 4880 Hernandez-Aguirre, 2022, Oncolytic viruses in immunotherapy, 375 Friedman, 2018, Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression, Sci. Rep., 8, 10.1038/s41598-018-32353-x Martuza, 1991, Experimental therapy of human glioma by means of a genetically engineered virus mutant, Science, 252, 854, 10.1126/science.1851332 Conry, 2018, Talimogene laherparepvec: First in class oncolytic virotherapy, Hum. Vaccin. Immunother., 14, 839, 10.1080/21645515.2017.1412896 Rehman, 2016, Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy, J. Immunother. Cancer, 4, 53, 10.1186/s40425-016-0158-5 Cassady, 2005, Human Cytomegalovirus TRS1 and IRS1 Gene Products Block the Double-Stranded-RNA-Activated Host Protein Shutoff Response Induced by Herpes Simplex Virus Type 1 Infection, J. Virol., 79, 8707, 10.1128/JVI.79.14.8707-8715.2005 MD, 2022 Cassady, 2017, Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates, Mol. Ther. Oncolytics, 5, 1, 10.1016/j.omto.2017.02.001 Miller, 2022, Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study, Clin. Cancer Res., 28, 498, 10.1158/1078-0432.CCR-21-2636 Markert, 2009, Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM, Mol. Ther., 17, 199, 10.1038/mt.2008.228 Markert, 2000, Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial, Gene Ther., 7, 867, 10.1038/sj.gt.3301205 Zindy, 2007, Genetic Alterations in Mouse Medulloblastomas and Generation of Tumors De novo from Primary Cerebellar Granule Neuron Precursors, Cancer Res., 67, 2676, 10.1158/0008-5472.CAN-06-3418 Kawauchi, 2012, A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma, Cancer Cell, 21, 168, 10.1016/j.ccr.2011.12.023 Friedman, 1985, Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med, J. Neuropathol. Exp. Neurol., 44, 592, 10.1097/00005072-198511000-00005 He, 1991, Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts, Lab. Invest., 64, 833 Ghonime, 2018, Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory, Transl. Oncol., 11, 86, 10.1016/j.tranon.2017.10.005 Jablonski, 2015, Novel Markers to Delineate Murine M1 and M2 Macrophages, PLOS ONE, 10, 10.1371/journal.pone.0145342 Veglia, 2021, Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice, J. Exp. Med., 218, 10.1084/jem.20201803 Ashburner, 2000, Gene Ontology: tool for the unification of biology, Nat. Genet., 25, 25, 10.1038/75556 Carbon, 2021, Gene Ontology Consortium. The Gene Ontology resource: enriching a GOld mine, Nucleic Acids Res, 49, D325, 10.1093/nar/gkaa1113 Zhang, 2019, Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse, Cancer Cell, 36, 302, 10.1016/j.ccell.2019.07.009 Ocasio, 2019, scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy, Nat. Commun., 10, 5829, 10.1038/s41467-019-13657-6 Dang, 2021, Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality, Cell Rep., 34, 10.1016/j.celrep.2021.108917 Lynn, 2020, Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics, SCIENCE IMMUNOLOGY, 16 Currier, 2017, Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation, Oncotarget, 8, 17412, 10.18632/oncotarget.14885 Otani, 2022, NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy, Clin. Cancer Res., 28, 1460, 10.1158/1078-0432.CCR-21-2347 Riemondy, 2022, Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma, Neuro. Oncol., 24, 273, 10.1093/neuonc/noab135 Riol-Blanco, 2005, The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed, J. Immunol., 174, 4070, 10.4049/jimmunol.174.7.4070 Cella, 1999, Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Nat. Med., 5, 919, 10.1038/11360 Vermeulen, 2018, Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma, Oncoimmunology, 7, 10.1080/2162402X.2017.1398877 Murata, 2018, High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma, J. Neurosurg., 128, 710, 10.3171/2016.11.JNS16991 Knipe, 2013 Kwong, 1988, Herpes simplex virus virion host shutoff function, J. Virol., 62, 912, 10.1128/jvi.62.3.912-921.1988 Vriend, 2020, Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets, Biochim. Biophys. Acta Mol. Basis Dis., 1866, 10.1016/j.bbadis.2020.165839 Korshunov, 2022, Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression, Acta Neuropathol., 144, 339, 10.1007/s00401-022-02460-1 Jiao, 2023, Ribosome biogenesis in disease: new players and therapeutic targets, Sig Transduct Target Ther., 8, 15, 10.1038/s41392-022-01285-4 Bish, 2014, RNA Binding Protein-Mediated Post-Transcriptional Gene Regulation in Medulloblastoma, Mol. Cells, 37, 357, 10.14348/molcells.2014.0008 Lopez, 1975, Genetics of natural resistance to herpesvirus infections in mice, Nature, 258, 152, 10.1038/258152a0 Lopez, 1980, Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci, Immunogenetics, 11, 87, 10.1007/BF01567772 Lundberg, 2007, Tumor Necrosis Factor (TNF) Protects Resistant C57BL/6 Mice against Herpes Simplex Virus-Induced Encephalitis Independently of Signaling via TNF Receptor 1 or 2, J. Virol., 81, 1451, 10.1128/JVI.02243-06 Casciati, 2020, Human Medulloblastoma Cell Lines: Investigating on Cancer Stem Cell-Like Phenotype, Cancers (Basel), 12, 226, 10.3390/cancers12010226 Ghonime, 2021, Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy, J. Immunother. Cancer, 9 Chen, 2017, Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models, Sci. Rep., 7, 2396, 10.1038/s41598-017-02503-8 Stuart, 2019, Comprehensive Integration of Single-Cell Data, Cell, 177, 1888, 10.1016/j.cell.2019.05.031 Hao, 2021, Integrated analysis of multimodal single-cell data, Cell, 184, 3573, 10.1016/j.cell.2021.04.048 Butler, 2018, Integrating single-cell transcriptomic data across different conditions, technologies, and species, Nat. Biotechnol., 36, 411, 10.1038/nbt.4096 Satija, 2015, Spatial reconstruction of single-cell gene expression data, Nat. Biotechnol., 33, 495, 10.1038/nbt.3192 Nestorowa, 2016, A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation, Blood, 128, e20, 10.1182/blood-2016-05-716480 Hafemeister, 2019, Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression, Genome Biol., 20, 296, 10.1186/s13059-019-1874-1 McGinnis, 2019, DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors, Cell Syst., 8, 329, 10.1016/j.cels.2019.03.003 McInnes, 2020, UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction, arXiv Zappia, 2018, Clustering trees: a visualization for evaluating clusterings at multiple resolutions, GigaScience, 7, giy083, 10.1093/gigascience/giy083 Phipson, 2021, propeller: testing for differences in cell type proportions in single cell data, arXiv Blanco-Carmona, 2022, Generating publication ready visualizations for Single Cell transcriptomics using SCpubr, arXiv Huang, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4, 44, 10.1038/nprot.2008.211 Sherman, 2022, DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update), Nucleic Acids Res., 50, W216, 10.1093/nar/gkac194